Adverse Events and Complications Associated With Intrathecal Drug Delivery Systems: Insights From the Manufacturer and User Facility Device Experience (MAUDE) Database-Reference-Cited by-同舟云学术

Adverse Events and Complications Associated With Intrathecal Drug Delivery Systems: Insights From the Manufacturer and User Facility Device Experience (MAUDE) Database

Published:2021-10 Issue:7 Volume:24 Page:1181-1189
ISSN:1094-7159
Container-title:Neuromodulation: Technology at the Neural Interface
language:en
Short-container-title:Neuromodulation: Technology at the Neural Interface

Author:

Goel Vasudha^ORCID,Yang Yan,Kanwar Siddak,Banik Ratan K.,Patwardhan Amol M.,Ibrahim Mohab,Sivanesan Eellan,Shankar Hariharan

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),Neurology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ner.13325

Reference22 articles.

1. Current perspectives on intrathecal drug delivery;Bottros;J Pain Res,2014

2. The Polyanalgesic consensus conference (PACC): recommendations for intrathecal drug delivery: Guidance for improving safety and mitigating risks;Deer;Neuromodulation.,2017

3. An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM);Smith;Ann Oncol,2005

4. Complications of intrathecal drug delivery systems;Kamran;Neuromodulation,2001

5. Intrathecal drug delivery systems (IDDS): the implantable systems performance registry (ISPR);Konrad;Neuromodulation,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical observation of the treatment of refractory cancer pain with cancer pain information platform and IDDS under home analgesia mode: A retrospective study;Medicine;2024-07-05

2. Functional outcomes & complications of hepatic artery infusion pumps by device manufacturer;HPB;2024-07

3. The Polyanalgesic Consensus Conference (PACC)®: Intrathecal Drug Delivery Guidance on Safety and Therapy Optimization When Treating Chronic Noncancer Pain;Neuromodulation: Technology at the Neural Interface;2024-05

4. Assessing the Reproducibility of Research Based on the Food and Drug Administration Manufacturer and User Facility Device Experience Data;Journal of Patient Safety;2024-03-13

5. Strategies for enhanced gene delivery to the central nervous system;Nanoscale Advances;2024